Health
Are Institutional Moves Concealing Serious Issues?
March 21, 2025 12:28 AM PDT| By Team Kalkine MediaHighlights,A major investment firm increases its stake in the medical group.,Hedge funds adjust positions with renewed interest.,Recent quarterly performance shows earnings and revenue surpassing initial expectations.,Operating within the healthcare...
Is Institutional Activity a Warning for Edgewise Therapeutics?
March 21, 2025 12:28 AM PDT| By Team Kalkine MediaHighlights:,Major financial institutions have increased their positions.,Notable participation by well‐known investment groups.,Continued advancement in clinical research for muscle disorders.,Edgewise Therapeutics (NASDAQ:EWTX) operates within the b...
How Is Globus Medical (NYSE:GMED) Expanding Its Market Engagement?
March 21, 2025 12:00 AM PDT| By Team Kalkine MediaHighlights,Proficio Capital Partners LLC acquired a new stake in Globus Medical during the fourth quarter.,Multiple firms increased their positions, contributing to a high institutional ownership percentage.,Globus Medical reported recent financial r...
How Do Development Programs Support Arcus Biosciences (NYSE:RCUS)’s Strategy?
March 21, 2025 12:00 AM PDT| By Team Kalkine MediaHighlights,Amundi expanded its stake in Arcus Biosciences during the fourth quarter.,Several firms including Quest Partners LLC and US Bancorp DE reported large increases in holdings.,Arcus Biosciences operates in the biopharmaceutical sector, focusi...
How Is Pediatrix Medical Group (NYSE:MD) Positioned in Neonatal Healthcare?
March 21, 2025 12:00 AM PDT| By Team Kalkine MediaHighlights,Amundi expanded its stake in Pediatrix Medical Group during the fourth quarter.,The company reported quarterly earnings above expectations in recent disclosures.,Pediatrix Medical Group operates in specialized pediatric and neonatal care a...
How Has Keros Therapeutics (NASDAQ:KROS) Attracted Institutional Capital?
March 21, 2025 12:00 AM PDT| By Team Kalkine MediaHighlights,AlphaQuest LLC significantly expanded its stake in Keros Therapeutics during the fourth quarter.,Multiple institutions, including Geode Capital Management and Barclays PLC, reported increased share positions.,Keros Therapeutics continues d...
Is Edgewise Therapeutics (NASDAQ:EWTX) Seeing a Shift in Market Confidence?
March 21, 2025 12:00 AM PDT| By Team Kalkine MediaHighlights,AlphaQuest LLC reduced its stake in Edgewise Therapeutics significantly during the fourth quarter.,Several institutions, including Quest Partners LLC and Meeder Asset Management Inc., expanded their positions.,Edgewise Therapeutics continu...
Is Xencor (NASDAQ:XNCR) Gaining Momentum Through Institutional Activity and Financial Results?
March 21, 2025 12:00 AM PDT| By Team Kalkine MediaHighlights,Xencor has surpassed recent earnings per share expectations.,Multiple institutional firms have modified their positions in Xencor.,The company maintains an active pipeline of therapeutic candidates in oncology and autoimmune treatment.,Xen...
How Is Rocket Pharmaceuticals (NASDAQ:RCKT) Positioned in the Gene Therapy Space?
March 21, 2025 12:00 AM PDT| By Team Kalkine MediaHighlights,Bank of New York Mellon Corp and other firms raised their holdings in Rocket Pharmaceuticals.,The company develops gene therapies for rare blood and immune system conditions.,Market metrics reflect strong liquidity and minimal debt exposur...
How Does AnaptysBio (NASDAQ:ANAB) Fit Into the Broader Biotech Landscape?
March 21, 2025 12:00 AM PDT| By Team Kalkine MediaHighlights,AlphaQuest LLC significantly increased its equity activity related to AnaptysBio in the recent quarter.,Other organizations, including Victory Capital Management, made notable portfolio adjustments.,AnaptysBio advances a diverse clinical p...
Is Johnson & Johnson’s Recent Performance Signaling Strength?
March 20, 2025 04:56 PM PDT| By Team Kalkine MediaIs Johnson & Johnson’s Recent Performance Signaling Strength?
Why Did Fresenius Medical Care See Increased Trading Activity?
March 20, 2025 04:50 PM PDT| By Team Kalkine MediaWhy Did Fresenius Medical Care See Increased Trading Activity?
What Led To The Recent Movement In Koninklijke Philips’ Stock?
March 20, 2025 04:47 PM PDT| By Team Kalkine MediaWhat Led To The Recent Movement In Koninklijke Philips’ Stock?
Is Market Sentiment Turning Against Stevanato Group?
March 20, 2025 10:59 AM PDT| By Team Kalkine MediaIs Market Sentiment Turning Against Stevanato Group?
Why Did Thrivent Financial Reduce Its Stake in Humana Inc. (NYSE:HUM)?
March 20, 2025 09:11 AM PDT| By Team Kalkine MediaHeadlines,Thrivent Financial for Lutherans lowered its position in Humana Inc. during the fourth quarter.,Several institutional firms adjusted their holdings in the insurance provider.,Over 90% of Humana’s stock is held by institutional investors.,Th...
Why Did Institutional Investors Increase Their Holdings in Humana Inc. (NYSE:HUM)?
March 20, 2025 08:05 AM PDT| By Team Kalkine MediaHeadlines,Institutional investors expanded their positions in Humana Inc. during recent quarters.,The company remains a key player in the health insurance sector, attracting significant institutional interest.,Multiple large firms adjusted their hold...
Can BioNTech's Institutional Momentum Propel Biotech Breakthroughs?
March 20, 2025 01:28 AM PDT| By Team Kalkine MediaHighlights,Institutional entities significantly increased their positions in BioNTech (NASDAQ:BNTX).,Market evaluations from financial professionals remain favorable.,BioNTech continues its commitment to innovative therapies for cancer and infectious...
Can BioNTech Redefine Medical Breakthroughs in Today's Dynamic Industry?
March 20, 2025 12:28 AM PDT| By Team Kalkine MediaHighlights,Extensive research and development drives cutting-edge medical treatments.,BioNTech (NASDAQ:BNTX) contributes to global health improvements through scientific innovation.,The biotechnology sector thrives on rigorous scientific methods and...
How Is Halozyme Therapeutics (NASDAQ:HALO) Navigating Market Trends?
March 20, 2025 12:00 AM PDT| By Team Kalkine MediaHighlights,PNC Financial Services Group Inc. adjusted its stake in Halozyme Therapeutics, reflecting a shift in market activity.,Institutional investors maintain significant holdings, with multiple firms increasing their positions.,The company contin...
How Is Embecta Corp. (NASDAQ:EMBC) Navigating the Medical Device Industry?
March 20, 2025 12:00 AM PDT| By Team Kalkine MediaHighlights,Institutional investors show varied interest in Embecta Corp., with some reducing and others increasing their holdings.,The company maintains dividend distributions, reflecting financial stability.,Embecta operates in the medical device se...